210 related articles for article (PubMed ID: 16781155)
1. Interaction of foot-and-mouth disease virus with dendritic cells.
Bayry J; Tough DF
Trends Microbiol; 2006 Aug; 14(8):346-7. PubMed ID: 16781155
[TBL] [Abstract][Full Text] [Related]
2. Innate immune responses against foot-and-mouth disease virus: current understanding and future directions.
Summerfield A; Guzylack-Piriou L; Harwood L; McCullough KC
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):205-10. PubMed ID: 19026453
[TBL] [Abstract][Full Text] [Related]
3. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.
Grubman MJ; Moraes MP; Diaz-San Segundo F; Pena L; de los Santos T
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):8-17. PubMed ID: 18400012
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus.
Bautista EM; Ferman GS; Gregg D; Brum MC; Grubman MJ; Golde WT
J Virol; 2005 Apr; 79(8):4838-47. PubMed ID: 15795269
[TBL] [Abstract][Full Text] [Related]
5. The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes.
Ostrowski M; Vermeulen M; Zabal O; Zamorano PI; Sadir AM; Geffner JR; Lopez OJ
J Virol; 2007 Sep; 81(17):9357-67. PubMed ID: 17567692
[TBL] [Abstract][Full Text] [Related]
6. [Construction of eukaryotic expression vector containing foot-and-mouth disease virus VP1 gene and its expression in dendritic cells].
Li J; Wang R; Shi W; Bian HX; Zhang L; Zhang L; Wang JX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):802-4. PubMed ID: 19737465
[TBL] [Abstract][Full Text] [Related]
7. Foot-and-mouth disease virus causes a decrease in spleen dendritic cells and the early release of IFN-α in the plasma of mice. Differences between infectious and inactivated virus.
Langellotti C; Quattrocchi V; Alvarez C; Ostrowski M; Gnazzo V; Zamorano P; Vermeulen M
Antiviral Res; 2012 Apr; 94(1):62-71. PubMed ID: 22387627
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes.
Guzylack-Piriou L; Bergamin F; Gerber M; McCullough KC; Summerfield A
Eur J Immunol; 2006 Jul; 36(7):1674-83. PubMed ID: 16783856
[TBL] [Abstract][Full Text] [Related]
9. Serotype-independent detection of foot-and-mouth disease virus.
Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
[TBL] [Abstract][Full Text] [Related]
10. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination.
Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B
Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
12. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.
Greenwood DL; Dynon K; Kalkanidis M; Xiang S; Plebanski M; Scheerlinck JP
Vaccine; 2008 May; 26(22):2706-13. PubMed ID: 18448209
[TBL] [Abstract][Full Text] [Related]
14. Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.
Golde WT; de Los Santos T; Robinson L; Grubman MJ; Sevilla N; Summerfield A; Charleston B
Transbound Emerg Dis; 2011 Aug; 58(4):283-90. PubMed ID: 21501424
[TBL] [Abstract][Full Text] [Related]
15. Baculovirus treatment fully protects mice against a lethal challenge of FMDV.
Molinari P; García-Nuñez S; Gravisaco MJ; Carrillo E; Berinstein A; Taboga O
Antiviral Res; 2010 Aug; 87(2):276-9. PubMed ID: 20580746
[TBL] [Abstract][Full Text] [Related]
16. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
17. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
18. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
19. Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells.
Robinson L; Windsor M; McLaughlin K; Hope J; Jackson T; Charleston B
J Virol; 2011 Mar; 85(5):2212-23. PubMed ID: 21177807
[TBL] [Abstract][Full Text] [Related]
20. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection.
Nfon CK; Toka FN; Kenney M; Pacheco JM; Golde WT
Viral Immunol; 2010 Feb; 23(1):29-41. PubMed ID: 20121400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
